Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Breast Cancer Res. 2024 Mar 13;26(1):46. doi: 10.1186/s13058-024-01805-w.
Breast Cancer Res. 2024.
PMID: 38481291
Free PMC article.
No abstract available.
Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
Hasan MK, Yu J, Chen L, Cui B, Widhopf Ii GF, Rassenti L, Shen Z, Briggs SP, Kipps TJ.
Hasan MK, et al. Among authors: widhopf ii gf.
Leukemia. 2017 Dec;31(12):2615-2622. doi: 10.1038/leu.2017.133. Epub 2017 May 3.
Leukemia. 2017.
PMID: 28465529
Free PMC article.
Item in Clipboard
Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib.
Yu J, Chen L, Cui B, Wu C, Choi MY, Chen Y, Zhang L, Rassenti LZ, Widhopf Ii GF, Kipps TJ.
Yu J, et al. Among authors: widhopf ii gf.
Leukemia. 2017 Jun;31(6):1333-1339. doi: 10.1038/leu.2016.368. Epub 2016 Dec 1.
Leukemia. 2017.
PMID: 27904138
Free PMC article.
Item in Clipboard
Cite
Cite